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Abstract The goal of this review is to analyse how recent
technical developments contributed to the biochemical charac-
terisation of protein complexes. Improvement of tags used for
protein puri¢cation, including in our own laboratory, and the
development of new strategies have allowed the use of generic
procedures for the puri¢cation of a wide variety of protein com-
plexes. Together with increased mass spectrometry sensitivity
and automation, this made high throughput studies of protein
complexes possible and allowed proteome-wide analyses of pro-
tein complexes. However, knowledge of protein complex com-
position, even at the cellular level, will not be su⁄cient to under-
stand their function. We suggest that the next level of analysis
in this area will be the de¢nition of internal subunit arrangement
in complexes as a ¢rst step toward more detailed structural
analyses.
" 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Proteins, which have enzymatic, structural and regulatory
functions, carry out the vast majority of all biological process-
es in cells. They most often do not work as monomeric entities
but rather interact with each other forming stable or transient
complexes. Interestingly, the sequences of higher eukaryotic
genomes suggest that the complexity of the cognate organisms
is not mediated by a dramatic increase in the number of genes
but rather by a more complex pattern of protein^protein in-
teractions [1]. Establishing the molecular interactions forming
the basis of these regulatory networks is one of the major
tasks of molecular biology in the post-genomic era. Because
of the wide diversity in the properties of proteins, this task is
technically more demanding than genome or transcriptome
analyses. Indeed, interactions between proteins in cells cover
a wide range of a⁄nities and half-lives from stable complexes
to transient interactions. Until recently, strategies allowing the
deciphering of complex interaction networks have been lack-
ing. However, data related to protein complex formation are
now growing steadily in databases thanks to the development
of new methodologies. In this review, we will give an overview
of some technical advances that allow high throughput pro-
tein complex analyses and discuss the results of the ¢rst ex-
amples of such studies. We also address some of the future
questions to be solved for a full understanding of protein
complex function.
2. Developments in mass spectrometry and a⁄nity puri¢cation
allow the e⁄cient puri¢cation of protein complexes
For decades, the bottleneck in protein analyses has resided
in protein identi¢cation. Relatively large amounts of protein
were required for their identi¢cation and cumbersome se-
quencing procedures allowed the processing of only a limited
number of samples [2]. Nowadays the protein identi¢cation by
mass spectrometry is very sensitive and relatively broadly
available [3]. Furthermore, a large part of the process can
be automated making high throughput studies possible. In
this new context, the strategy that seems to be best adapted
to characterise cellular protein complexes is their puri¢cation
followed by subunit identi¢cation by mass spectrometry. Thus
solving the protein identi¢cation problem created a new de-
mand for methods making it possibly to rapidly and e⁄ciently
purify su⁄cient amounts of intact protein complexes of ap-
propriate purity.
Originally, protein complexes were puri¢ed using classical
biochemical methods [4]. This process was generally time-con-
suming, especially for low abundant complexes as very large
amounts of starting material (hundreds of grams of cells or
tissues) and numerous puri¢cation steps were needed. Yields
were usually low and the procedure was so long that less
stable complexes were not preserved. Most importantly, a
new set of puri¢cation steps had to be empirically designed
for each new complex. Nevertheless, such classical puri¢cation
procedures have allowed the puri¢cation of relatively large
complexes such as the human spliceosome [5^8].
The development of a⁄nity puri¢cation and epitope tag-
ging techniques greatly reduced the time and costs of puri¢-
cation [9]. Usually proteins targeted for puri¢cation with their
associated partners are modi¢ed by addition of a peptide suit-
able for a⁄nity puri¢cation (for example the His6 tag). Fu-
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sion of the target protein sequence and peptide tag coding
sequence is done using standard DNA cloning techniques.
The recombinant gene thus created is then introduced and
expressed in the cognate host for which a transformation pro-
cedure must be available. For yeasts such as Saccharomyces
cerevisiae or Schizosaccharomyces pombe this step is per-
formed by introduction of a plasmid containing a tagged
gene or more elegantly by gene replacement mediated by
site-speci¢c in vivo recombination [10]. For higher eukaryotes
transient or stable transfections are performed. An alternative
strategy to the use of peptides is to raise antibodies against
one of the components and use of immunoa⁄nity chromatog-
raphy [11]. However, production of antibodies is time-con-
suming and it remains uncertain whether reagents of su⁄cient
quality will be obtained. Therefore this method cannot be
used as a general puri¢cation strategy, especially for high
throughput purposes.
There are many di¡erent a⁄nity puri¢cation tags [12], but
many of them have low a⁄nity for their cognate ligands such
that low or medium abundance proteins are recovered in low
yield. It is di⁄cult to directly compare di¡erent a⁄nity puri-
¢cation tags since there are few comparative studies and only
a few publications of high throughput protein complex puri-
¢cation data. In our laboratory, major progress in protein
complex puri¢cation was made by development of the tandem
a⁄nity puri¢cation (TAP) method [13,14]. This method is
based on two successive a⁄nity chromatography steps. Orig-
inally it was developed for yeast and the tag was introduced
by in vivo recombination. The tag fused to a target protein is
composed of protein A having very high a⁄nity for IgG, a
TEV protease cleavage site and calmodulin binding peptide
having high a⁄nity for calmodulin. An extract containing the
TAP-tagged target protein is mixed with IgG a⁄nity resin
before being incubated with TEV protease that will release
the target protein by cleavage. This eluate is used for a second
a⁄nity step where the target protein will bind to calmodulin
in the presence of calcium before release of the puri¢ed com-
plex by EGTA chelating calcium ions essential for calmodulin
binding (Fig. 1). The puri¢cation bu¡ers have been optimised
for highest yield, while generally maintaining protein complex
integrity in an environment not too highly divergent from the
intracellular conditions. Introduction of two di¡erent a⁄nity
puri¢cation steps greatly enhances the speci¢city of the puri-
¢cation procedure. In most cases, puri¢cation from 2 l of
yeast culture (roughly 10 g of wet yeast cells) gives su⁄cient
amounts of complex to visualise proteins by staining of so-
dium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) gels and identify subunits by mass spectrome-
try. The puri¢cation of yeast U1 snRNP and histone methyl-
ase complexes are concrete examples of the e⁄ciency of the
TAP method. In both cases, these complexes were puri¢ed
independently by standard biochemical procedures. In the
case of U1 snRNP, isolation from 2 l of yeast culture gave
cleaner, more intact complexes and a higher yield than puri-
¢cation from 16 l of yeast culture using immunoa⁄nity chro-
matography (making use of a high a⁄nity antibody) followed
by His tag nickel a⁄nity chromatography [13,15]. In the case
of the histone methyltransferase complex the TAP method
made it possible to reduce the yeast culture volume from
300 l to 5 l and to use only two standard and pre-optimised
a⁄nity steps instead of seven custom-developed puri¢cation
steps [16].
Due to the puri¢cation strategy, the module composing the
TAP needs to be organised with protein A being at the pro-
tein extremity. Thus, TAP tag cassettes allowing introduction
at both ends of proteins have been constructed and used suc-
cessfully [14]. Additional variants of the TAP tag strategy
have been described that are particularly useful in cases where
some subunits belong to several di¡erent complexes, a rather
common situation in cells. In the split TAP tag strategy, the
two modules making the TAP tag (TEV cleavage site^protein
A and calmodulin binding peptide respectively) can be inde-
pendently fused to di¡erent targets to selectively recover com-
plex(es) containing simultaneously the two target proteins
[14,17]. Alternatively, undesired complexes may be selectively
removed by fusing a speci¢c subunit to a protein A module
lacking a TEV protease cleavage site (subtraction strategy)
[18]. The TAP strategy has been used to purify complexes
from a wide variety of cellular compartments. Thus, with
some modi¢cation of the standard conditions by addition of
appropriate detergents, it has even been used to purify mem-
brane protein complexes [19]. While the TAP strategy was
originally developed using yeast protein complexes as a model
system, it was designed to be easily adapted to other organ-
isms. To our knowledge, it has currently been used in S. ce-
Fig. 1. Overview of the TAP strategy.
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revisiae, S. pombe, trypanosomes, human, Drosophila and
plant cells in culture as well as in Xenopus oocytes [20^23].
So far over 100 studies have reported the use of the TAP
method to purify and identify subunits of the complexes in
low throughput study. Interestingly, comparison of ortholo-
gous complexes puri¢ed from various sources has revealed
that they share similar subunits [19,21,24]. Thus an alternative
strategy based on phylogenetic conservation can easily be de-
veloped if the TAP strategy cannot be easily applied to a
given system. In one case, a yeast homologue of a human
target protein was puri¢ed using the TAP strategy and its
partners were identi¢ed [25]. Database searches revealed the
human homologues of these partners that were shown to as-
sociate with the original human target. Recently, an alterna-
tive strategy was proposed. It relied on the puri¢cation of
TAP-tagged human protein expressed in Drosophila cells
that had been depleted of the homologous protein by
RNAi-mediated gene inactivation. Depletion of the endoge-
nous homologous protein was implemented to make more
partner subunits available for association with the target pro-
tein. This alternative strategy was thus reported to improve
the number and level of partners recovered [20]. It remains to
be shown, however, whether the extra RNAi step would have
been truly required if the corresponding Drosophila protein
had been TAP-tagged. Indeed, as it is likely that it would
have had a higher a⁄nity for its partners, similar results might
have been obtained without the extra cost and work required
by the RNAi step.
Comparison of the TAP puri¢cation results to the data
about known protein^protein interactions suggests that this
method has a low false negative and probably false positive
error rate [26,27]. However, a⁄nity puri¢cation methods all
su¡er from some limitations. First, the addition of a tag, large
or small, to the protein may change its properties, causing
changes in complex stability or composition. However, from
our experience most genes can be tagged at one or the other
extremity without major e¡ects. If the addition of the tag is
deleterious for a cell, alternative subunits may be targeted.
Consistent with our data, a high throughput study (see below)
revealed that 82% of the yeast essential proteins were still
functional when fused to the TAP tag at their C-termini
[19]. Some complexes are relatively unstable and may disas-
semble during puri¢cation. While the TAP method allowed
the identi¢cation of transient interaction, further analyses
will be required to evaluate the a⁄nity required for such de-
tection. Another problem that may be encountered is that the
target protein belongs to several di¡erent complexes. While
this is not problematic if partners need solely to be identi¢ed,
this may create trouble if the activity of a given complex needs
to be tested or if the various complexes are in very di¡erent
stoichiometry. In the latter cases, the subtraction or the split
TAP tag strategies described above may provide some solu-
tions.
The major problem in all puri¢cation methods is the co-
puri¢cation of ‘contaminating’ proteins. This includes abun-
dant cellular proteins such as cytoskeletal proteins, translation
factors (particularly for RNA^protein complexes) and molec-
ular chaperones [19]. It is often di⁄cult to conclude whether
these ‘contaminants’ represent true endogenous partners or
arti¢cial associations induced by cell disruption. In this vein,
the use of a triple tag to improve further puri¢cation has been
suggested and such a construct prepared [28]. It has been
noticed, however, that because of constraints on the bu¡ers,
the three di¡erent puri¢cation steps cannot be performed in a
row. Furthermore, puri¢cation of the master cell cycle kinase
Cdc28 using this triple tag but only two puri¢cation steps led
to the identi¢cation of numerous proteins still likely to be
contaminants [19,28,29]. Thus it remains to be demonstrated
that a triple puri¢cation step and/or this speci¢c construct are
truly advantageous over the two-step TAP tag process in
terms of yield and purity.
Additional tags have been used to purify protein complexes
from various sources by a⁄nity chromatography. Among
those, the Flag tag has been quite popular; this small peptide
tag is selectively recognised by a monoclonal antibody [30].
Major drawbacks with the utilisation of the Flag tag as a
single-step puri¢cation tool come, as for any a⁄nity tag,
from its speci¢city and contaminant levels. However, in addi-
tion the cost of Flag tag-based puri¢cation is also a major
concern given the price of a monoclonal antibody-based col-
umn to which must be added the price of the competing pep-
tide used, in some cases, for elution. Glutathione S-transferase
(GST), His6, biotinylation substrates and many other tags
used for the puri¢cation of recombinant proteins overex-
pressed in Escherichia coli [12] have also been used for puri-
¢cation of complexes [15]. However, these have not been
adopted extensively, probably owing to their limited a⁄nity
and/or high background levels [13]. Future work will certainly
Table 1
Comparison of the high throughput biochemical protein interaction studies
Method TAPa HMS-PCI (Flag)b
Number of genes processed 1739 726
Fraction of successful integration 1548 (89%) ^
Fraction of proteins expressed at detectable level 1167 (75%) ^
Fraction of successful puri¢cation 589 (874) (61%) 600 (83%)
Fractions of puri¢cations with interacting proteins 460 (78%) 493 (82%)
Number of interacting proteins in raw data V4000 8111
Number of interacting proteins in ¢ltered data 3225 (80%) 3617 (45%)
Number of di¡erent proteins identi¢ed by screens 1440 1578
Suggested false negative ratec 15% 50%
Proposed number of di¡erent complexes 225 ^
Internal reproducibility 70% sometimes 20%
Validation by immunoprecipitation ^ 74% (64/86)
aFrom Gavin et al. [19].
bFrom Ho et al. [29].
cFrom Edwards et al. [26].
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be facilitated by development of better tags for protein com-
plex puri¢cation as well by increases in mass spectrometry
sensitivity and throughput.
3. Global look at protein interaction data obtained from yeast
Due to the recent technical progress, high throughput bio-
chemical studies of protein complexes are now possible. So far
such large-scale analyses together with global analysis of low
throughput data on protein complexes and interactions are far
from saturation. This means that direct comparison of all
available data cannot yet reveal the complete picture of cel-
lular protein interaction networks or allow the evaluation of
methods e⁄ciency. Even for yeast, for which the greatest
numbers of protein interaction studies at the proteomic level
have been performed, the overlap between di¡erent ap-
proaches is still relatively low.
Two large-scale biochemical protein interaction studies
have been performed (Table 1). One of them followed the
TAP puri¢cation method (TAP data) [19] mentioned above,
while the other used a single-step a⁄nity puri¢cation with
Flag tag (HMS-PCI data) [29]. Another major di¡erence be-
tween the two studies resides in the strategy used to express
the target proteins. While for TAP puri¢cation tagged pro-
teins were expressed at their natural level from endogenous
promoters, the HMS-PCI analysis used proteins overex-
pressed from plasmids using inducible promoters. In both
cases, puri¢cation was followed by SDS^PAGE and mass
spectrometry. In addition, the data obtained by these bio-
chemical approaches may be compared with two global yeast
two-hybrid (Y2H) screens that identi¢ed binary protein inter-
actions [31,32].
As mentioned before, the overlap between these di¡erent
approaches is relatively low, so it is di⁄cult to assess directly
the quality of the data. The puri¢cation methods assay only
the composition of the complex and do not give any informa-
tion about interactions between particular subunits. The two-
hybrid system assays only for interactions between two pro-
teins and cannot distinguish between stable and transient in-
teractions, making the comparison more di⁄cult.
Two global Y2H screens surprisingly show slightly less than
10% overlap [33] as only 159 interactions among the 1648
found in total by Ito et al. and Uetz et al. are shared. In
addition to some slight di¡erences in the experimental design,
the internal error rate of the Y2H assay probably contributes
to this problem. This conclusion is supported by a very strik-
ing example presented in a study by Matthews et al. [34]. This
group re-evaluated previously published two-hybrid data
using their own two-hybrid assay. From the 72 previously
reported Y2H interactions, only 19 were recapitulated. This
suggests a very high dependence of interaction detection upon
the exact experimental conditions used for Y2H, for example
expression vector and reporter types.
Comparison of the biochemical protein interaction studies
(TAP and HMS-PCI data) for which 115 targets were shared
also showed only about 10% overlap in the proteins recovered
[33]. Even though this cannot be directly compared to inter-
action results obtained with Y2H, this could suggest that pu-
ri¢cation methods have a similar error rate as Y2H. However,
this may also result from di¡erences in the two methods due
to the two strategies to express target proteins. For example,
protein overexpression and the single-step puri¢cation in
HMS-PCI may have generated a higher background than
the low level expression and two-step puri¢cation used in
the TAP strategy. A further complication in the comparison
of the results resides in the fact that both studies used ¢ltering
criteria to remove contaminating proteins from the raw data.
After this process, more than 50% of the potentially interact-
ing proteins identi¢ed by HMS-PCI were removed while for
TAP this represented only about 20%. The high throughput
TAP puri¢cation study estimated that internal reproducibility
of identi¢ed proteins was above 70%, thus a maximum of 30%
of data should be treated with caution. For the HMS-PCI
approach, a similar value is not available even though it is
indicated that for a limited number of samples reproducibility
was only 20%. Re-evaluation of 80 randomly chosen interac-
tions by immunoprecipitation con¢rmed 74% of them.
These limitations in the comparison of the e⁄ciency of the
various strategies will be resolved with time and the accumu-
lation of more complete data sets. Nevertheless, comparison
of all four high throughput studies with data about known
yeast complexes deposited in the MIPS database suggest that
the TAP method has the lowest false negative rate (15%)
followed by the HMS-PCI method (50%) and Y2H (45^
75%) [26]. Comparison of common targets analysed by the
TAP and the HMS-PCI studies to published data about bina-
ry interaction reveals that the TAP method is 30% better in
¢nding previously known interactions [35]. This result is con-
sistent with the previous comparison. It is much more di⁄cult
to estimate false positive error rates than false negative. Even
if the crystal structure of a complex is known, some interac-
tions not present in the crystal may be biologically relevant,
for example during assembly of the complex. One method that
can give some estimation of false positive error rates is eval-
uating protein interaction data using mRNA co-expression
pro¢les optioned from microarray experiments. The rationale
behind this analysis is that interacting proteins are usually
similarly regulated. Again interactions identi¢ed by the TAP
method gave the highest correlation for co-expression trends
suggesting a rather low false positive error rate [27]. Accumu-
lation of the data about protein interactions and their cross-
validation by di¡erent methods will in the future allow more
accurate estimations of the positive error rate of each strategy.
Overall, the current studies have demonstrated that techni-
cal conditions for high throughput biochemical analyses of
protein interactions are now available. However, because
such studies are still in their infancy, further technical advan-
ces will certainly arise before a de¢nitive optimum strategy is
found.
4. What is next: analysis of internal structure of protein
complexes?
Identi¢cation of the protein complex subunits does not pro-
vide the data about its internal structure and interactions of
these components. Without such information it is very di⁄-
cult to understand the molecular mechanism of their action,
especially when the complex does not have any obvious enzy-
matic activity. For example, numerous data related to the
composition of the spliceosome and protein complexes in-
volved in splicing have accumulated for years but there is
still only limited structural information and in most cases, it
is not known how these factors contribute to splicing catalysis
[36].
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There is no general way to obtain structural information
about protein complexes. Obviously crystal structures show
all stable interactions and architecture of the complex but
this method requires very large amounts of pure homogeneous
complex to succeed, a goal that is often di⁄cult and time-
consuming to reach. An additional problem encountered dur-
ing the crystallisation of large complexes is that they cannot
usually be reconstituted from recombinant components. As an
example, the structure of ribosomes was solved only because
these large assemblies can be isolated in high amounts from a
natural source [37].
Thus, because crystallisation studies are di⁄cult, alternative
strategies leading to lower structural resolution are often at-
tractive. Electron microscopy is one such method [38]. Un-
fortunately in most cases resolution is too low (more than
10 AQ ) to determine the precise location of speci¢c subunits,
even if immunolocalisation is used. Phylogenetic data may,
however, be useful in this case. Indeed, if the crystal structure
of a related complex is known and/or if additional data about
protein interactions in the complex are available, electron mi-
croscopy and homology modelling may lead to the generation
of useful models. As an example, Alloy et al. published the
structural model of the yeast exosome based on electron mi-
croscopy analysis of TAP-puri¢ed exosome, structural simi-
larity with the related bacterial RNA-degrading enzyme
PNPase and additional protein interaction data [39] (see
also [40]). Similarly, in a very elegant study, Lutzmann et
al. presented reconstitution and the rough structure of seven
nucleoporins [41]. Their data were derived from the electron
microscopy structure of di¡erent subcomplexes overexpressed
in bacteria. A major advantage with the use of electron mi-
croscopy is that a limited amount of material is required and
the sample does not need to be extremely homogeneous.
At an even lower scale the two-hybrid assay may be used to
identify interacting subunits inside a complex of interest. Ob-
viously, the high false positive error rate encountered in
screens and, to a lesser extent, the high false negative error
rate become less important when pairwise interactions are
analysed. Similar information can be derived from biochemi-
cal approaches that assay binary interactions in arti¢cial en-
vironments such as GST pull-down or far-Western. Obvi-
ously, combination of these methods gives more accurate
and credible data, which make it possible to derive a relatively
good picture of complex architectures. An example can be
taken from the analysis of the bacterial RNA degradation
complex called degradosome [42]. It is composed of the
above-mentioned PNPase, endoribonuclease E, RNA helicase
RhlB and the Krebs cycle enzyme enolase. Using each ap-
proach (two-hybrid, far-Western and immunoprecipitation)
only partial data about subunit interaction were obtained.
Combination of these results suggests, however, that the com-
plex is arranged on RNase E dimers to which all other com-
ponents bind. In the near future, these studies may also be
combined with the probing of protein microarrays to detect
binary interaction information. While this strategy is still in its
infancy, the ¢rst available data suggest that useful informa-
tion may be obtained with this technique [43].
Another approach, which potentially should give very ac-
curate data about interaction sites of the complex, is chemical
cross-linking [44]. The puri¢ed complex is usually treated with
cross-linking chemicals before fractionation of the reaction
products by SDS^PAGE. The cross-linked species are then
identi¢ed by their size, immunoreactivity and/or direct se-
quence determination. The strategy seems to be simple, but
identi¢cation of cross-linked proteins especially for large com-
plexes is always a problem. Another limitation often encoun-
tered is that various cross-linkers have to be tested and con-
ditions optimised for each complex without a de¢nitive
guarantee that an existing contact will ever be detected. Given
the limited number of publications reporting the use of cross-
linking with mass spectrometry to assay the complex architec-
ture, it is currently di⁄cult to assess which method will prove
to be optimal. However, reliable results have clearly been
obtained with this strategy. For example, the nucleoporin
complex discussed above was analysed by cross-linking beside
electron microscopy [45]. The puri¢ed native complex from
yeast was treated with cross-linking reagent before fractiona-
tion by SDS^PAGE. Proteins present in cross-linked species
were identi¢ed by matrix-assisted laser desorption/ionization
time of £ight mass spectrometry. The resulting interactions
were not as detailed as those obtained by electron microscopy
but cross-links were in most cases consistent with the struc-
tural model. A major problem in cross-linking is a resolution
of cross-linked species. For the six-subunit nucleoporin com-
plex some bands contained more than two proteins leaving
some ambiguities on the actual cross-linked partners. For
larger complexes this problem will obviously become even
more important.
One of the strategies to overcome these di⁄culties is to
identify cross-linked peptides rather than cross-linked pro-
teins. Such analyses identify the sites of interactions between
proteins while simultaneously bypassing the need to resolve
cross-linked species. Bennet et al. used thio-cleavable cross-
linkers [46]. Comparison of the peptide maps obtained from
trypsin-digested cross-linked dimers in the presence and ab-
sence of a thiol reagent made it possible to identify cross-
linked species [46]. Unfortunately, in most cases the concen-
tration of such peptides is relatively low, so for more complex
samples it is di⁄cult to analyse the mass spectrum. Another
way to identify cross-linked peptides is using isotope-tagged
cross-linking reagents. It is easy to see cross-linked species in a
mass spectrum by mixing 1/1 deuterium-labelled and unla-
belled cross-linker [47].
New mass spectrometry methods, which allow the transfer
of whole protein complexes to the gas phase, should also be
very useful in analysing the architecture of protein complexes
[48]. These methods can very accurately show masses of the
complexes and heterogeneity of the samples. Dissection of the
complex by tandem mass spectrometry to sub-particles can
give information about interactions between subunits. Combi-
nation of these methods with chemical cross-linking could be
extremely useful in structural analysis of protein complexes.
5. Conclusion
Overall, while major developments in protein complex pu-
ri¢cation and mass spectrometry are likely to facilitate analy-
sis of protein interactions in the future, the current technology
is ripe to make large-scale analysis of protein complexes pos-
sible. We are thus likely to obtain soon an accurate descrip-
tion of cellular complexes. Proteomic studies will reveal in
parallel the organisation of these proteins in the even larger
structure constituted by cellular compartments such as the
nucleolus or mitochondria [49^51]. Understanding the dynam-
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ics and function of such protein interaction networks will be a
challenge for the years to come.
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